C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
01/2007
01/11/2007	DE112004001159T5 Sulfonimidhaltige Verbindung und ihre Verwendung in Polymerelektrolytmembranen für elektrochemische Zellen Sulfonimidhaltige compound and its use in polymer electrolyte membranes for electrochemical cells
01/11/2007	DE112004001158T5 Fluorierte Sulfonamidverbindungen und daraus hergestellte Polymer-Elektrolytmembranen zur Verwendung in elektrochemischen Zellen Sulfonamide compounds and fluorinated polymer electrolyte membranes produced therefrom for use in electrochemical cells
01/10/2007	EP1740559A1 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
01/10/2007	CN1894241A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5
01/10/2007	CN1894235A N-(4-carbamimidoyl-benzyl) -2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
01/10/2007	CN1894225A (3,4-disubstituted)propanoic carboxylates as SLP (EDG) receptor agonists
01/10/2007	CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
01/10/2007	CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
01/04/2007	WO2007002764A2 Di-substituted oxadiazoles as cxc-chemokine receptor ligands
01/04/2007	WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/04/2007	US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents
01/04/2007	US20070004642 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
01/04/2007	CA2613607A1 Di-substituted oxadiazoles as cxc-chemokine receptor ligands
01/04/2007	CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
01/03/2007	EP1737811A1 Cetp inhibitors
01/03/2007	EP1658273B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
01/03/2007	CN1293034C New gamma selective retinoids
01/02/2007	US7157584 Benzimidazole derivative and use thereof
01/02/2007	US7157476 Aminofurazan compounds useful as protein kinase inhibitors
01/02/2007	US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
01/02/2007	US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases
12/2006
12/28/2006	WO2006049941A3 Diaryl ureas as cb1 antagonists
12/28/2006	US20060293370 Sulfonamide compounds and uses thereof
12/27/2006	EP1735319A1 Inhibitors of histone deacetylase
12/27/2006	EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006	CN1291983C Luminescent element material and luminescent element comprising the same
12/26/2006	US7153880 Substituted diphenyl heterocycles useful for treating HCV infection
12/21/2006	WO2006134317A1 Oxadiazole derivatives as dgat inhibitors
12/21/2006	CA2610188A1 Oxadiazole derivatives as dgat inhibitors
12/20/2006	EP1732884A1 Sulphonamide derivatives
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882337A Substituted oxadiazolidinediones ALS PAI-1 inhibitors
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006	US7151104 Pyrazolopyridines as cyclin dependent kinase inhibitors
12/14/2006	WO2006131336A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS
12/14/2006	WO2006115835A3 Benzothiophene hydroxamic acid derivatives
12/14/2006	WO2006105291A3 Heterocyclical chromophore architectures with novel electronic acceptor systems
12/14/2006	CA2610310A1 Polycyclic oxadiazoles or isoxazoles and their use as s1p receptor ligands
12/13/2006	EP1730106A1 Dendron and dendrimer, method of producing the same, and method of producing a thioacetal compound
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006	CN1289467C Dibenzylamine compound and medicinal use thereof
12/12/2006	US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/07/2006	WO2006128657A1 Sphingolipids
12/07/2006	WO2006058088A3 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/05/2006	US7145016 Nitrobenzodifuroxan compounds, including their salts, and methods thereof
12/05/2006	US7144908 Prophylaxis, therapy of respiratory system disorders
12/05/2006	US7144901 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
12/05/2006	US7144876 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/05/2006	CA2360313C Glucocorticoid receptor modulators
11/2006
11/30/2006	WO2006125637A1 O-(phenyl/heterocyclyl)methyl oxime ether compounds for combating animal pests
11/30/2006	WO2006017409A3 1,3-disubstituted heteroaryl nmda/nr2b antagonists
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	EP1725231A1 Triazole, oxadiazole and thiadiazole derivatives as ppar modulators for the treatment of diabetes
11/29/2006	EP1651642A4 Pna monomer and precursor
11/28/2006	US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/28/2006	US7141592 Substituted oxadiazolidinediones
11/28/2006	US7141591 e.g., 2-methyl-2-{4-[3-(4-tert-Butyl-phenyl)-[1,2,4]oxadiazol-5-ylmethoxy]-2-methyl-phenoxy}propionic acid or its ethyl ester; dyslipidemia, syndrome X, heart failure, hypercholesteremia, cardiovascular disease, diabetes, anorexia, etc.
11/23/2006	WO2006123486A1 Method for producing 1,2,4-oxadiazol derivative
11/23/2006	WO2006122949A1 Malononitriles and their use as pesticides
11/23/2006	WO2005112932A3 Raf modulators and methods of use
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264475 Compounds, compositions and methods for inhibiting or treating hiv-1
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060261328 Blue light-emitting compounds, processes of preparing the same, and luminescent element including the same
11/22/2006	EP1723128A1 Heteroaryl-ureas and their use as glucokinase activators
11/22/2006	EP1723126A2 Novel mch receptor antagonists
11/22/2006	EP1722782A2 Compounds, compositions and methods for inhibiting or treating hiv-1
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors
11/21/2006	US7138414 Antidiabetic agents
11/21/2006	US7138413 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/16/2006	WO2006122150A1 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
11/16/2006	WO2006120133A2 Process for coloring keratin fibers comprising metal complexes
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	CA2606783A1 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
11/14/2006	US7135487 Sulphonamide derivatives
11/08/2006	EP1718967A2 METHODS OF DETECTING Lp-PLA2 ACTIVITY
11/08/2006	EP1718628A1 Cinnamic amides, process for their preparation, and pharmaceutical compositions containing them
11/08/2006	CN1859908A 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists
11/02/2006	WO2006069808A3 Nitro-substituted phenyl-piperazine compounds, their preparation and use in medicaments
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247223 Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	CA2603986A1 Benzothiophene hydroxamic acid derivatives
11/01/2006	CN1856480A P-38 kinase inhibitors
10/2006
10/31/2006	US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/31/2006	CA2406685C Oxadiazole derivatives having anticancer effects
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/25/2006	CN1850812A Imidazole derivative, and its preparing method and pharmaceutical use for anti tubercle bacillus
10/24/2006	US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism
10/24/2006	CA2261848C Cell adhesion inhibitors

1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 72